1RU Stock Overview

A medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. More details

1RU fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	3/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 2.1% below our estimate of its fair value

Earnings are forecast to grow 47.02% per year

Earnings grew by 470% over the past year

Analysts in good agreement that stock price will rise by 21.7%

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Medartis Holding AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medartis Holding
Historical stock prices
Current Share Price	CHF 79.90
52 Week High	CHF 82.40
52 Week Low	CHF 76.60
Beta	1.07
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-0.50%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	1RU	DE Medical Equipment	DE Market
7D	3.5%	-0.3%	1.1%
1Y	n/a	-9.9%	16.0%

Return vs Industry: Insufficient data to determine how 1RU performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 1RU performed against the German Market.

Price Volatility

Is 1RU's price volatile compared to industry and market?
1RU volatility
1RU Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	6.6%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: 1RU's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 1RU's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1997	883	Matthias Schupp	www.medartis.com

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names.

Medartis Holding AG Fundamentals Summary

How do Medartis Holding's earnings and revenue compare to its market cap?
1RU fundamental statistics
Market cap	€1.01b
Earnings (TTM)	€3.79m
Revenue (TTM)	€241.27m

266.0x

P/E Ratio

4.2x

P/S Ratio

Is 1RU overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1RU income statement (TTM)
Revenue	CHF 224.83m
Cost of Revenue	CHF 46.15m
Gross Profit	CHF 178.68m
Other Expenses	CHF 175.16m
Earnings	CHF 3.53m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 19, 2025

Earnings per share (EPS)	0.28
Gross Margin	79.47%
Net Profit Margin	1.57%
Debt/Equity Ratio	35.6%

How did 1RU perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/21 09:39
End of Day Share Price	2025/05/20 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medartis Holding AG is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Eric Le Berrigaud	Bryan Garnier & Co
Maria Vara Fernández	Bryan Garnier & Co
Hugo Solvet	Bryan Garnier & Co